Leweke FM - Search Results

1

Chronic pubertal cannabinoid treatment as a behavioural model for aspects of schizophrenia: effects of the atypical antipsychotic quetiapine.

Leweke FM, Schneider M. Leweke FM, et al. Int J Neuropsychopharmacol. 2011 Feb;14(1):43-51. doi: 10.1017/S1461145710000842. Epub 2010 Aug 3. Int J Neuropsychopharmacol. 2011. PMID: 20678304 Free article.

2

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use.

Leweke FM, Giuffrida A, Koethe D, Schreiber D, Nolden BM, Kranaster L, Neatby MA, Schneider M, Gerth CW, Hellmich M, Klosterkötter J, Piomelli D. Leweke FM, et al. Schizophr Res. 2007 Aug;94(1-3):29-36. doi: 10.1016/j.schres.2007.04.025. Epub 2007 Jun 13. Schizophr Res. 2007. PMID: 17566707 Free article.

3

Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats.

Schneider M, Schömig E, Leweke FM. Schneider M, et al. Among authors: leweke fm. Addict Biol. 2008 Sep;13(3-4):345-57. doi: 10.1111/j.1369-1600.2008.00117.x. Addict Biol. 2008. PMID: 18782382

4

Schizophrenia.

Leweke FM. Leweke FM. Curr Top Behav Neurosci. 2009;1:387-96. doi: 10.1007/978-3-540-88955-7_16. Curr Top Behav Neurosci. 2009. PMID: 21104393

5

Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels.

Klugmann M, Klippenstein V, Leweke FM, Spanagel R, Schneider M. Klugmann M, et al. Among authors: leweke fm. Int J Neuropsychopharmacol. 2011 May;14(4):505-17. doi: 10.1017/S1461145710001562. Epub 2011 Jan 7. Int J Neuropsychopharmacol. 2011. PMID: 21211107 Free article.

6

Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior.

Schneider M, Kasanetz F, Lynch DL, Friemel CM, Lassalle O, Hurst DP, Steindel F, Monory K, Schäfer C, Miederer I, Leweke FM, Schreckenberger M, Lutz B, Reggio PH, Manzoni OJ, Spanagel R. Schneider M, et al. Among authors: leweke fm. J Neurosci. 2015 Oct 14;35(41):13975-88. doi: 10.1523/JNEUROSCI.1937-15.2015. J Neurosci. 2015. PMID: 26468198 Free PMC article.

7

Therapeutic Potential of Cannabinoids in Psychosis.

Leweke FM, Mueller JK, Lange B, Rohleder C. Leweke FM, et al. Biol Psychiatry. 2016 Apr 1;79(7):604-12. doi: 10.1016/j.biopsych.2015.11.018. Epub 2015 Nov 28. Biol Psychiatry. 2016. PMID: 26852073 Review.

8

Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention.

Leweke FM, Mueller JK, Lange B, Fritze S, Topor CE, Koethe D, Rohleder C. Leweke FM, et al. CNS Drugs. 2018 Jul;32(7):605-619. doi: 10.1007/s40263-018-0539-z. CNS Drugs. 2018. PMID: 30022465 Review.

9

Cannabis use and psychosis: a review of reviews.

Hasan A, von Keller R, Friemel CM, Hall W, Schneider M, Koethe D, Leweke FM, Strube W, Hoch E. Hasan A, et al. Among authors: leweke fm. Eur Arch Psychiatry Clin Neurosci. 2020 Jun;270(4):403-412. doi: 10.1007/s00406-019-01068-z. Epub 2019 Sep 28. Eur Arch Psychiatry Clin Neurosci. 2020. PMID: 31563981

10

Cannabidiol as a treatment option for schizophrenia: recent evidence and current studies.

Schoevers J, Leweke JE, Leweke FM. Schoevers J, et al. Among authors: leweke fm, leweke je. Curr Opin Psychiatry. 2020 May;33(3):185-191. doi: 10.1097/YCO.0000000000000596. Curr Opin Psychiatry. 2020. PMID: 32073423 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters